{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:14:17Z","timestamp":1780910057924,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1092649"],"award-info":[{"award-number":["2022R1A2C1092649"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A6A1A03042854"],"award-info":[{"award-number":["2020R1A6A1A03042854"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020M3A9C8015798"],"award-info":[{"award-number":["NRF-2020M3A9C8015798"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.taap.2025.117656","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:35:18Z","timestamp":1763771718000},"page":"117656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Aurocyanide, an active metabolite of auranofin, exerts cytoprotective effects via ROS-mediated Nrf2 activation in HepG2 cells"],"prefix":"10.1016","volume":"506","author":[{"given":"Undarmaa","family":"Otgontenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokwon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117656_bb0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2012.110","article-title":"Nrf2: a potential target for new therapeutics in liver disease","volume":"92","author":"Bataille","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2025.117656_bb0010","first-page":"255","article-title":"Auranofin: a unique oral chrysotherapeutic agent, Semin","volume":"13","author":"Blodgett","year":"1984","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2025.117656_bb0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0002-9343(86)90539-5","article-title":"Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial","volume":"81","author":"Bombardier","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.taap.2025.117656_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bcp.2012.11.016","article-title":"The Nrf2 cell defense pathway: Keap1-dependent and -independent mechanisms of regulation","volume":"85","author":"Bryan","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41577-020-00491-x","article-title":"Regulation of inflammation by the antioxidant haem oxygenase 1","volume":"21","author":"Campbell","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.taap.2025.117656_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I clinical trial results of auranofin, a novel antiparasitic agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2025.117656_bb0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bbrc.2011.12.009","article-title":"Investigation of a potential mechanism for the inhibition of SmTGR by auranofin and its implications for plasmodium falciparum inhibition","volume":"417","author":"Caroli","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2025.117656_bb0040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2015.6378","article-title":"TrxR1 as a potent regulator of the Nrf2-Keap1 response system","volume":"23","author":"Cebula","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2025.117656_bb0045","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1111\/bph.14465","article-title":"Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPAR\u03b3 attenuates LPS-mediated lung inflammation","volume":"175","author":"Cho","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0050","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.taap.2025.117656_bb0055","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.cmet.2022.09.019","article-title":"The rheumatoid arthritis drug auranofin lowers leptin levels and exerts antidiabetic effects in obese mice","volume":"34","author":"Cox","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2025.117656_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2025.117656_bb0065","first-page":"268","article-title":"Dicyanogold (I) is a common human metabolite of different gold drugs","volume":"20","author":"Elder","year":"1993","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.taap.2025.117656_bb0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0278-6915(99)00082-4","article-title":"Antioxidant functions of sulforaphane: a potent inducer of phase II detoxication enzymes","volume":"37","author":"Fahey","year":"1999","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2025.117656_bb0075","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1074\/jbc.M109.051714","article-title":"Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation","volume":"285","author":"Fourquet","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117656_bb0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.taap.2010.06.005","article-title":"Sulforaphane protects microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response","volume":"247","author":"Gan","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0085","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/rheumatology\/36.8.870","article-title":"Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis","volume":"36","author":"Glenn\u00e5s","year":"1997","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.taap.2025.117656_bb0090","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/0006-2952(90)90113-Y","article-title":"The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes\u2014II. Evidence for the formation and biological activity of aurocyanide","volume":"39","author":"Graham","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0095","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0006-2952(84)90178-3","article-title":"The effect of cyanide on the uptake of gold by red blood cells","volume":"33","author":"Graham","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0100","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1155\/MBD.1994.395","article-title":"The cellular metabolism and effects of gold complexes","volume":"1","author":"Graham","year":"1994","journal-title":"Metal-Based Drugs"},{"key":"10.1016\/j.taap.2025.117656_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10787-007-0020-y","article-title":"Aurocyanide, dicyano-aurate (I), a pharmacologically active metabolite of medicinal gold complexes","volume":"16","author":"Graham","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117656_bb0110","doi-asserted-by":"crossref","first-page":"20096","DOI":"10.1074\/jbc.273.32.20096","article-title":"Human placenta thioredoxin reductase: isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds","volume":"273","author":"Gromer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2025.117656_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-229947","article-title":"Fatality from potassium gold cyanide poisoning","volume":"12","author":"Harmon","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.taap.2025.117656_bb0120","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/tx000130l","article-title":"In vivo metabolism of tert-butyl hydroperoxide to methyl radicals: EPR spin-trapping and DNA methylation studies","volume":"13","author":"Hix","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.taap.2025.117656_bb0125","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3390\/antiox9111040","article-title":"Auranofin attenuates non-alcoholic fatty liver disease by suppressing lipid accumulation and NLRP3 inflammasome-mediated hepatic inflammation in vivo and in vitro","volume":"9","author":"Hwangbo","year":"2020","journal-title":"Antioxidants (Basel)."},{"key":"10.1016\/j.taap.2025.117656_bb0130","first-page":"90","article-title":"Pharmacokinetics of auranofin in animals","volume":"8","author":"Intoccia","year":"1982","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.taap.2025.117656_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(98)00037-0","article-title":"Redox regulation of cellular signaling","volume":"11","author":"Kamata","year":"1999","journal-title":"Cell. Signal."},{"key":"10.1016\/j.taap.2025.117656_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117635","article-title":"Sen, synthesis, characterization and anticancer activity in vitro evaluation of novel dicyanoaurate(I)-based complexes","volume":"251","author":"Karada\u011f","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117656_bb0145","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s42003-021-02345-1","article-title":"Auranofin prevents liver fibrosis by system xc-mediated inhibition of NLRP3 inflammasome","volume":"4","author":"Kim","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.taap.2025.117656_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12272-023-01438-1","article-title":"Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin","volume":"46","author":"Kim","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.taap.2025.117656_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.advenzreg.2006.01.007","article-title":"Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species","volume":"46","author":"Kobayashi","year":"2006","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.taap.2025.117656_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105066","article-title":"The FDA-approved drug auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-\u03baB signaling","volume":"25","author":"Laplantine","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.taap.2025.117656_bb0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-\u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.taap.2025.117656_bb0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1080\/15548627.2020.1739442","article-title":"Sulforaphane activates a lysosome-dependent transcriptional program to mitigate oxidative stress","volume":"17","author":"Li","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2025.117656_bb0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.taap.2025.117656_bb0180","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.taap.2025.117656_bb0185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","article-title":"Role of Nrf2 in oxidative stress and toxicity","volume":"53","author":"Ma","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2025.117656_bb0190","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10787-012-0149-1","article-title":"The biological activity of auranofin: implications for novel treatment of diseases","volume":"20","author":"Madeira","year":"2012","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.taap.2025.117656_bb0195","first-page":"279","article-title":"Gold complexes in the treatment of rheumatoid arthritis","volume":"41","author":"Messori","year":"2004","journal-title":"Met. Ions Biol. Syst."},{"key":"10.1016\/j.taap.2025.117656_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2008.04.003","article-title":"(\u2212)-epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells","volume":"476","author":"Na","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2025.117656_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of Nrf2\u2014an update","volume":"66","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117656_bb0210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.fct.2012.01.031","article-title":"Evaluation of hepatotoxicity and oxidative stress in rats treated with tert-butyl hydroperoxide","volume":"50","author":"Oh","year":"2012","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2025.117656_bb0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0168-8278(01)00142-8","article-title":"Oxidative stress-related molecules and liver fibrosis","volume":"35","author":"Parola","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2025.117656_bb0220","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1021\/acs.inorgchem.9b03072","article-title":"Direct observation of methylmercury and auranofin binding to selenocysteine in thioredoxin reductase","volume":"59","author":"Pickering","year":"2020","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.taap.2025.117656_bb0225","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/ars.2016.6925","article-title":"Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system","volume":"27","author":"Ren","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.taap.2025.117656_bb0230","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.bcp.2003.09.038","article-title":"Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c","volume":"67","author":"Rigobello","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R D."},{"key":"10.1016\/j.taap.2025.117656_bb0240","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/0006-2952(90)90112-X","article-title":"The activation of gold complexes by cyanide produced by polymorphonuclear leukocytes\u2014I. The effects of aurocyanide on the oxidative burst of polymorphonuclear leukocytes","volume":"39","author":"Rudkowski","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0163-7258(90)90045-4","article-title":"Glutathione-dependent protection against oxidative injury","volume":"47","author":"Shan","year":"1990","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2025.117656_bb0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2025.117656_bb0255","first-page":"71","article-title":"The cellular pharmacology of auranofin, Semin","volume":"17","author":"Snyder","year":"1987","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.taap.2025.117656_bb0260","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.taap.2016.08.003","article-title":"Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3\u03b2","volume":"307","author":"Song","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006158","article-title":"Cytoprotective Nrf2 pathway is induced in chronically txnrd1-deficient hepatocytes","volume":"4","author":"Suvorova","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2025.117656_bb0270","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.6429854","article-title":"Intestinal uptake and metabolism of auranofin, a new oral gold-based antiarthritis drug","volume":"225","author":"Tepperman","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.taap.2025.117656_bb0275","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1155\/MBD.1994.433","article-title":"Transport of the dicyanogold(I) anion","volume":"1","author":"Tepperman","year":"1994","journal-title":"Metal-Based Drugs"},{"key":"10.1016\/j.taap.2025.117656_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2022.130171","article-title":"Metformin-ROS-Nrf2 connection in the host defense mechanism against oxidative stress, apoptosis, cancers, and ageing","volume":"1866","author":"Udono","year":"2022","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.taap.2025.117656_bb0285","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","article-title":"Biologic actions and pharmacokinetic studies of auranofin","volume":"75","author":"Walz","year":"1983","journal-title":"Am. J. Med."},{"key":"10.1016\/j.taap.2025.117656_bb0290","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.freeradbiomed.2024.09.035","article-title":"Naturally-derived modulators of the Nrf2 pathway and their roles in the intervention of diseases","volume":"225","author":"Wang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117656_bb0295","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2044.1986.tb12920.x","article-title":"Acute poisoning with gold cyanide","volume":"41","author":"Wright","year":"1986","journal-title":"Anaesthesia"},{"key":"10.1016\/j.taap.2025.117656_bb0300","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1081\/CLT-100108516","article-title":"Cholestatic hepatitis caused by acute gold potassium cyanide poisoning","volume":"39","author":"Wu","year":"2001","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.taap.2025.117656_bb0305","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2025.117656_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108272","article-title":"Auranofin: past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2025.117656_bb0315","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1111\/febs.16135","article-title":"The two faces of cyanide: an environmental toxin and a potential novel mammalian gasotransmitter","volume":"289","author":"Zuhra","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2025.117656_bb0320","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s42255-025-01225-w","article-title":"Regulation of mammalian cellular metabolism by endogenous cyanide production","volume":"7","author":"Zuhra","year":"2025","journal-title":"Nat. Metab."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25004326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:51:19Z","timestamp":1780908679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25004326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"alternative-id":["S0041008X25004326"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117656","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aurocyanide, an active metabolite of auranofin, exerts cytoprotective effects via ROS-mediated Nrf2 activation in HepG2 cells","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117656"}}